Studies conducted in vitro, wherein melanoma cells transfected with MGMT were incubated with various alkylating agents including melphalan, chlorambucil, busulfan, and thiotepa, demonstrated no discernible difference in cell survival post-treatment (30). This evidence concerns the gene MGMT and melanoma.